Hemorrhagic H7N9 Avian Flu + Pandemic Blood Shortage = $57,000,000 award to Cellphire for Thrombosomes
What does the government do when it is expecting a massive Hemorrhagic H7N9 Avian Influenza pandemic and simultaneously expects a pandemic related national blood shortage??? Well, they award Cellphire a $57 million dollar cost plus contract for Thrombosomes.
Thrombosomes are Cellphire's experimental freeze dried blood platelet-derived hemostatic agent for control of noncompressible hemorrhage. When nothing else stops the blood pouring out of your body, hopefully Thrombosomes will.
More details are in the video, see below for links.